QUOTE AND NEWS
Benzinga  Sep 13  Comment 
BioDelivery Sciences International (NASDAQ: BDSI) announced a positive outcome of the Company's pivotal pharmacokinetic study for BEMA Buprenorphine/Naloxone (BNX), which is being developed for the potential treatment of opioid dependence and...
Penny Stock DD  Sep 4  Comment 
RTTNews) - Shares of BioDelivery Sciences International Inc. (BDSI:Quote) are up more than 500% year-to-date and trade over $4. As the company moves closer towards reporting the study results of its late-stage product candidate, BNX for the...
Globe Newswire  Jun 28  Comment 
NEW YORK, NY and ATLANTA, GA, June 28, 2012 (GLOBE NEWSWIRE) -- Remark Media, Inc. (Nasdaq: MARK), a global digital media company, today announced that it has completed its acquisition of Banks.com, Inc. (OTCQB: BNNX), a financial media company that
Benzinga  Jun 28  Comment 
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced positive results of a recently completed pharmacokinetic study (BNX-106) examining the effects of multiple BEMA Buprenorphine/Naloxone (BNX) films administered concurrently. This...
Benzinga  Feb 28  Comment 
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on the development program for BEMA Buprenorphine/Naloxone that should result in a New Drug...
StreetInsider.com  Nov 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Banks.com+%28BNX%29+Gets+Delisting+Letter+from+NYSE+Amex%3B+Will+Appeal+Determination/6977291.html for the full story.
StreetInsider.com  Jun 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Banks.com+%28BNX%29+Receives+Noncompliance+Notice+from+NYSE+Amex/6602629.html for the full story.
StreetInsider.com  Dec 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Banks.com+%28BNX%29+Announces+Acquisition+of+FileLater.com/6173286.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki